GenScript, a global biotech leader, showcased its cutting-edge AI capabilities in recombinant protein production and drug discovery during its Open Day event at its Singapore facility on April 16th. The event welcomed over 50 representatives from the Singapore biotech community.
GenScript’s pioneering AI technologies are revolutionizing the way recombinant proteins are produced and new drugs are discovered. By leveraging AI algorithms and machine learning, the company is accelerating the development of novel therapeutics and enhancing the efficiency of protein manufacturing processes.
The Open Day provided attendees with valuable insights into GenScript’s state-of-the-art facilities and innovative solutions. Industry experts and thought leaders shared their knowledge and experiences, highlighting the immense potential of AI in driving the future of biotechnology and life sciences.
